Dr. Peter Schneider

Biography

 Peter Schneider obtained his Ph.D. in 1971 at the Swiss Federal Institute of Technology, Zürich (ETHZ). From 1971 he has worked for Ciba-Geigy in chemistry research developing antibiotics, anti-tumorals and antivirals and has been involved in several marketed products. He was responsible for building-up the Molecular Diversity unit (Compound Archive, Natural Products, Microbiological Transformations, and Combinatorial Chemistry) and was a member of the Steering Committee for the Ciba and Chiron collaboration. After the merger of Ciba with Sandoz to Novartis, he led the Combinatorial Chemistry unit introducing the single bead approach and other new technologies. In 2002 he was appointed as Head of Chemistry at Arpida Ltd. working in the field of anti-infectives. Currently, he is consulting for several small Biotech companies and is a member of Ki Consulting AG. He holds 31 issued patents and has published 39 articles in leading journals.

Research Interest

 Antibiotics, Anti-tumorals and Antivirals